Amniotic Umbilical Cord Particulate for Discogenic Pain

Derek Buck
{"title":"Amniotic Umbilical Cord Particulate for Discogenic Pain","authors":"Derek Buck","doi":"10.7556/jaoa.2019.138","DOIUrl":null,"url":null,"abstract":"Abstract Context Discogenic low back pain is the most common type of low back pain and is a major cause of morbidity worldwide. Current nonoperative treatment options are limited in efficacy and lack evidence of long-term pain relief; thus, there is an unmet clinical need for an effective treatment for patients with discogenic pain. Amniotic membrane and umbilical cord (AMUC) particulate may be useful in relieving pain and inhibiting the degenerative cascade in patients with discogenic pain by reducing inflammation. Objective To evaluate the effectiveness of AMUC particulate for discogenic pain. Methods Six months of conservative therapy failed in patients who had discogenic pain confirmed by magnetic resonance imaging and provocative discography. They subsequently received intradiskal injection of 50 to 100 mg of AMUC particulate for cervical, lumbar, and lumbosacral disks. Results A total of 11 patients with 20 disks were included. Before treatment, all patients reported severe pain, and 10 patients took opioids daily. After treatment, the median reported pain relief was 40%, 50%, and 75% at 1-month (n=6), 3 months (n=8), and 6 months (n=5), respectively. Complete pain relief was noted in 1 patient; however, 2 patients (18%) reported no pain relief at 1 and 3 months. No adverse events, repeated procedures, or complications occurred. Conclusion This preliminary evidence suggests that a single intradiskal injection of AMUC particulate is safe and may provide symptomatic pain relief in some patients with discogenic pain.","PeriodicalId":16639,"journal":{"name":"Journal of Osteopathic Medicine Journal of Osteopathic Medicine","volume":"70 1","pages":"814 - 819"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Osteopathic Medicine Journal of Osteopathic Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7556/jaoa.2019.138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Abstract Context Discogenic low back pain is the most common type of low back pain and is a major cause of morbidity worldwide. Current nonoperative treatment options are limited in efficacy and lack evidence of long-term pain relief; thus, there is an unmet clinical need for an effective treatment for patients with discogenic pain. Amniotic membrane and umbilical cord (AMUC) particulate may be useful in relieving pain and inhibiting the degenerative cascade in patients with discogenic pain by reducing inflammation. Objective To evaluate the effectiveness of AMUC particulate for discogenic pain. Methods Six months of conservative therapy failed in patients who had discogenic pain confirmed by magnetic resonance imaging and provocative discography. They subsequently received intradiskal injection of 50 to 100 mg of AMUC particulate for cervical, lumbar, and lumbosacral disks. Results A total of 11 patients with 20 disks were included. Before treatment, all patients reported severe pain, and 10 patients took opioids daily. After treatment, the median reported pain relief was 40%, 50%, and 75% at 1-month (n=6), 3 months (n=8), and 6 months (n=5), respectively. Complete pain relief was noted in 1 patient; however, 2 patients (18%) reported no pain relief at 1 and 3 months. No adverse events, repeated procedures, or complications occurred. Conclusion This preliminary evidence suggests that a single intradiskal injection of AMUC particulate is safe and may provide symptomatic pain relief in some patients with discogenic pain.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
羊膜脐带颗粒治疗盘源性疼痛
椎间盘源性腰痛是最常见的腰痛类型,是世界范围内发病率的主要原因。目前非手术治疗方案的疗效有限,缺乏长期缓解疼痛的证据;因此,对椎间盘源性疼痛患者有效治疗的临床需求尚未得到满足。羊膜和脐带(AMUC)颗粒可能有助于缓解疼痛,并通过减少炎症抑制椎间盘源性疼痛患者的退行性级联反应。目的评价AMUC颗粒治疗椎间盘源性疼痛的疗效。方法对经磁共振显像和诱发性椎间盘造影证实的椎间盘源性疼痛患者进行6个月的保守治疗。他们随后接受椎间盘内注射50至100mg的AMUC颗粒用于颈椎、腰椎和腰骶盘。结果共纳入11例患者,共20个椎间盘。治疗前,所有患者均报告剧烈疼痛,10例患者每天服用阿片类药物。治疗后,在1个月(n=6)、3个月(n=8)和6个月(n=5)时,报告的疼痛缓解中位数分别为40%、50%和75%。1例患者疼痛完全缓解;然而,2名患者(18%)报告在1个月和3个月时疼痛没有缓解。无不良事件、重复手术或并发症发生。结论单次椎间盘内注射AMUC颗粒是安全的,可以缓解一些椎间盘源性疼痛患者的症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Spontaneous neonatal subcutaneous emphysema: analysis of neonatal management Further insight on AOA ophthalmology residency program closure data Cranial osteopathic techniques and electroencephalogram (EEG) alpha power: a controlled crossover trial Response to “Further insight on AOA ophthalmology residency program closure data” UGRC 2021 recommendations on GME transition: pros and cons, opportunities and limitations
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1